Depressive symptoms were assessed using the Center of Epidemiological Studies–Depression Scale (CES-D); a score ≥16 was considered elevated. In a prospective cohort, data were available of 1,104 participants (mean age 70 years; 61% women, 69% Hispanics). At baseline, 198 participants (18%) had elevated depressive symptoms. After a mean of 14 years, 101 participants had had incident strokes; 87 strokes were ischemic. The cumulative incidence of stroke of any type was 14% and 13%, respectively. Having elevated depressive symptoms significantly increased the risk of ischemic stroke (HR 1.75). Stroke risk increased with depression severity. Every 5-point increase in CES-D score further increased the risk of ischemic stroke by 12%.
1. Simonetto M, et al. AAN 2019, S1.003.
Posted on
Previous Article
« Laquinimod does not improve motor scores in Huntington disease Next Article
OV101 (gaboxadol) as therapy of Angelman syndrome »
« Laquinimod does not improve motor scores in Huntington disease Next Article
OV101 (gaboxadol) as therapy of Angelman syndrome »
Table of Contents: AAN 2019
Featured articles
Letter from the Editor
Interview with Prof. Natalia Rost
Alzheimer's Disease and other Dementias
Amyloid PET in cognitively impaired patients
Tight blood pressure control lowers risk of mild cognitive impairment
Epilepsy
Headache and Migraine
Multiple Sclerosis and NMOSD
Immune tolerance by peptide-loaded tolerogenic dendritic cells
Biotin, ocrelizumab, and ibudilast in progressive MS
No increased MS relapse risk postpartum
Neuromuscular Disorders
First-ever effective and safe treatment of CMT1A
Parkinson’s Disease and other Movement Disorders
Leukaemia and hypertension therapies tested in Parkinson’s disease
Stroke
Miscellaneous
Possibly lifesaving therapy in refractory PML
New AAN guideline for treating Tourette syndrome
Subspecialty teleneurology: feasible and highly valued
Related Articles
July 30, 2019
Long term safety of diazepam nasal spray
July 30, 2019
Encouraging results zilucoplan in myasthenia gravis
July 30, 2019
McDonald Criteria MS often misapplied and misunderstood
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com